SCHEMBL22727030

SCHEMBL22727030

CCC(O)(CCO)c1ccnc(NC(=O)OC(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NR3C2 P08235 2/20 0.39
▸ AR P10275 2/20 0.39
▸ ATR Q13535 1/20 0.38
▸ GSK3B P49841 2/20 0.37
▸ DYRK1A Q13627 1/20 0.37
▸ IGF1R P08069 1/20 0.37
▸ P2RX3 P56373 1/20 0.36
▸ SCN9A Q15858 1/20 0.36
▸ SREBF2 Q12772 1/20 0.36
▸ CYP17A1 P05093 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ AAK1 Q2M2I8 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CCR2 P41597 2/20 0.35
▸ ACSS2 Q9NR19 1/20 0.35
▸ PTGER1 P34995 1/20 0.35
▸ TGFBR1 P36897 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12695291 0.84 ALDH1A1 (0.45) ALDH1A1GAAL3MBTL1NR3C2AR
SCHEMBL12540480 0.80 ATR (0.42) ALDH1A1GAAL3MBTL1NR3C2AR
SCHEMBL13331892 0.77 ATR (0.44) ALDH1A1GAAL3MBTL1NR3C2AR
SCHEMBL13563525 0.76 GAA (0.49) ALDH1A1GAAL3MBTL1NR3C2AR
SCHEMBL15077819 0.75 IGF1R (0.46) NR3C2ATRGSK3BDYRK1AIGF1R
SCHEMBL2406509 0.75 NR3C2 (0.47) NR3C2ATRIGF1RCYP17A1CCR2
SCHEMBL1940483 0.75 IGF1R (0.48) NR3C2ATRGSK3BDYRK1AIGF1R
SCHEMBL29575346 0.75 IGF1R (0.48) NR3C2ATRGSK3BDYRK1AIGF1R
SCHEMBL15354529 0.75 RIOK2 (0.50) NR3C2ATRGSK3BDYRK1AIGF1R
SCHEMBL29272503 0.74 BRAF (0.44) ALDH1A1GAAL3MBTL1NR3C2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976189-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2024-07-03 — — EP disclosed
WO-2020239658-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2020-12-03 — — WO disclosed
Send feedback